Showing results (531-540 of 632) with videos related to
Sort By:
Pageof 64
Human Vaccines|October 29, 2010
AFFITOME® technology in neurodegenerative diseases: the doubling advantageAchim Schneeberger, Markus Mandler, Frank Mattner, et al.Human Vaccines|October 27, 2010
TroVax, a recombinant modified vaccinia Ankara virus encoding 5T4: lessons learned and future developmentDae Won Kim, Vikram Krishnamurthy, Steven D Bines, et al.Human Vaccines|September 22, 2010
HPV vaccine acceptance, utilization and expected impacts in the U.S.: Where are we now?Amanda F Dempsey, Divya A PatelHuman Vaccines|September 22, 2010
Successful hepatitis B immunization in non- and low responding health care workersUlrich Heininger, Muriel Gambon, Verena Gruber, et al.Human Vaccines|December 15, 2010
Optimized development of a candidate strain of inactivated EV71 vaccine and analysis of its immunogenicity in rhesus monkeysChenghong Dong, Jingjing Wang, Longding Liu, et al.Human Vaccines|December 15, 2010
Young-adult carriers of Neisseria meningitidis in Puglia (Italy): will the pattern of circulating meningococci change following the introduction of meningococcal serogroup C conjugate vaccines?Cinzia Germinario, Silvio Tafuri, Christian Napoli, et al.Human Vaccines|December 15, 2010
Could the United States experience rubella outbreaks as a result of vaccine refusal and disease importation?Brynn E Berger, Saad B OmerHuman Vaccines|May 21, 2010
The Spanish human papillomavirus vaccine consensus group: a working modelJavier Cortés-Bordoy, Federico Martinón-Torres, Human Vaccines|April 8, 2010
Development of TNFSF as molecular adjuvants for ALVAC HIV-1 vaccinesJun Liu, Mario OstrowskiPageof 64